WKN: | 789617 |
ISIN: | US09062X1037 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Biotechnologie |
Weshalb die Biogen-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 28. August 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 1999 | 6,04 | 29,48 | 388,08% |
2 | 2000 | 29,48 | 68,16 | 131,21% |
3 | 2013 | 102,13 | 186,94 | 83,04% |
4 | 2011 | 45,73 | 78,21 | 71,03% |
5 | 2004 | 27,17 | 45,50 | 67,46% |
6 | 2014 | 186,94 | 260,67 | 39,44% |
7 | 2010 | 33,98 | 45,73 | 34,58% |
8 | 2012 | 78,21 | 102,13 | 30,58% |
9 | 1998 | 4,91 | 6,04 | 23,01% |
10 | 2022 | 217,60 | 256,90 | 18,06% |
11 | 2009 | 30,61 | 33,98 | 11,01% |
12 | 2021 | 198,86 | 217,60 | 9,42% |
13 | 2001 | 68,16 | 72,49 | 6,35% |
14 | 2017 | 250,94 | 266,15 | 6,06% |
15 | 2007 | 34,32 | 36,38 | 6,00% |
16 | 2019 | 256,14 | 266,90 | 4,20% |
17 | 2015 | 260,67 | 259,70 | -0,37% |
18 | 2006 | 34,59 | 34,32 | -0,78% |
19 | 2016 | 259,70 | 250,94 | -3,37% |
20 | 2018 | 266,15 | 256,14 | -3,76% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2002 | 72,49 | 29,29 | -59,59% |
2 | 2024 | 234,40 | 143,85 | -38,63% |
3 | 2020 | 266,90 | 198,86 | -25,49% |
4 | 2005 | 45,50 | 34,59 | -23,98% |
5 | 2025 | 143,85 | 117,75 | -18,14% |
6 | 2008 | 36,38 | 30,61 | -15,86% |
7 | 2023 | 256,90 | 234,40 | -8,76% |
8 | 2003 | 29,29 | 27,17 | -7,24% |
9 | 2018 | 266,15 | 256,14 | -3,76% |
10 | 2016 | 259,70 | 250,94 | -3,37% |
11 | 2006 | 34,59 | 34,32 | -0,78% |
12 | 2015 | 260,67 | 259,70 | -0,37% |
13 | 2019 | 256,14 | 266,90 | 4,20% |
14 | 2007 | 34,32 | 36,38 | 6,00% |
15 | 2017 | 250,94 | 266,15 | 6,06% |
16 | 2001 | 68,16 | 72,49 | 6,35% |
17 | 2021 | 198,86 | 217,60 | 9,42% |
18 | 2009 | 30,61 | 33,98 | 11,01% |
19 | 2022 | 217,60 | 256,90 | 18,06% |
20 | 1998 | 4,91 | 6,04 | 23,01% |